↓ Skip to main content

Dove Medical Press

Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway

Overview of attention for article published in OncoTargets and therapy, October 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
10 Mendeley
Title
Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway
Published in
OncoTargets and therapy, October 2020
DOI 10.2147/ott.s253691
Pubmed ID
Authors

Hongfei Tong, Zhen Huang, Hui Chen, Bin Zhou, Yi Liao, Zhaohong Wang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 2 20%
Student > Bachelor 1 10%
Student > Doctoral Student 1 10%
Researcher 1 10%
Professor 1 10%
Other 0 0%
Unknown 4 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 40%
Veterinary Science and Veterinary Medicine 1 10%
Medicine and Dentistry 1 10%
Unknown 4 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2020.
All research outputs
#23,513,156
of 26,178,577 outputs
Outputs from OncoTargets and therapy
#2,104
of 3,021 outputs
Outputs of similar age
#378,224
of 436,664 outputs
Outputs of similar age from OncoTargets and therapy
#45
of 86 outputs
Altmetric has tracked 26,178,577 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,021 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,664 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.